Earnings Summary

Resmed Inc.’s revenue jumped 7.17% since last year same period to $1196.98Mn in the Q1 2024. On a quarterly growth basis, Resmed Inc. has generated 2.94% jump in its revenue since last 3-months.

Resmed Inc.’s net profit jumped 29.24% since last year same period to $300.49Mn in the Q1 2024. On a quarterly growth basis, Resmed Inc. has generated 43.91% jump in its net profits since last 3-months.

Resmed Inc.’s net profit margin jumped 20.6% since last year same period to 25.1% in the Q1 2024. On a quarterly growth basis, Resmed Inc. has generated 39.8% jump in its net profit margins since last 3-months.

Resmed Inc.’s price-to-earnings ratio after this Q1 2024 earnings stands at 32.24.

Resmed Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.06 - a 7.85% jump from last quarter’s estimates.

Resmed Inc.’s earning per share (EPS) estimates for the current year stand at 2.06.

Resmed Inc.’s earning per share (EPS) jumped 26.79% since last year same period to 2.13 in the Q1 2024. This indicates that the Resmed Inc. has generated 26.79% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Resmed Inc.’s return on assets (ROA) stands at 0.12.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Resmed Inc.’s return on equity (ROE) stands at 0.22.

Resmed Inc. declared 0.48 dividend per share during the earnings announcement for Q1 2024.